These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 25330014)
1. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes. Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014 [TBL] [Abstract][Full Text] [Related]
2. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells. Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829 [TBL] [Abstract][Full Text] [Related]
3. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets. Song R; Lisovsky I; Lebouché B; Routy JP; Bruneau J; Bernard NF PLoS Pathog; 2014 Jan; 10(1):e1003867. PubMed ID: 24453969 [TBL] [Abstract][Full Text] [Related]
4. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N; J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235 [TBL] [Abstract][Full Text] [Related]
5. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. Boulet S; Kleyman M; Kim JY; Kamya P; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF AIDS; 2008 Jul; 22(12):1487-91. PubMed ID: 18614872 [TBL] [Abstract][Full Text] [Related]
6. KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors. Jiang Y; Chen O; Cui C; Zhao B; Han X; Zhang Z; Liu J; Xu J; Hu Q; Liao C; Shang H BMC Infect Dis; 2013 Sep; 13():405. PubMed ID: 24059286 [TBL] [Abstract][Full Text] [Related]
7. Under representation of the inhibitory KIR3DL1 molecule and the KIR3DL1+/BW4+ complex in HIV exposed seronegative individuals. Guerini FR; Lo Caputo S; Gori A; Bandera A; Mazzotta F; Uglietti A; Zanzottera M; Maserati R; Clerici M J Infect Dis; 2011 May; 203(9):1235-9. PubMed ID: 21398398 [TBL] [Abstract][Full Text] [Related]
8. KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina. Habegger de Sorrentino A; Sinchi JL; Marinic K; López R; Iliovich E Immunology; 2013 Oct; 140(2):273-9. PubMed ID: 23789883 [TBL] [Abstract][Full Text] [Related]
9. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection. Parsons MS; Boulet S; Song R; Bruneau J; Shoukry NH; Routy JP; Tsoukas CM; Bernard NF J Infect Dis; 2010 Nov; 202 Suppl 3():S356-60. PubMed ID: 20887224 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians. Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808 [TBL] [Abstract][Full Text] [Related]
13. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B Front Immunol; 2018; 9():1855. PubMed ID: 30147699 [No Abstract] [Full Text] [Related]
15. [The favorable effects of KIR3DS1 and Bw4(80Ile) on viral set point and CD4 count decline in HIV-1 patients with acutely infected with HIV-1 infection]. Wang R; Liu Y; Lu XF; Liu ZY; Li Z; Zhang X Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(35):2819-2823. PubMed ID: 30248785 [No Abstract] [Full Text] [Related]
16. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs. Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292 [TBL] [Abstract][Full Text] [Related]
17. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407 [TBL] [Abstract][Full Text] [Related]
18. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455 [TBL] [Abstract][Full Text] [Related]
19. Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. Long BR; Erickson AE; Chapman JM; Barbour JD; Vu BA; Ho EL; Lanier LL; Sauer MM; Carvalho KI; Nixon DF; Kallas EG Immunology; 2010 Feb; 129(2):186-96. PubMed ID: 19824915 [TBL] [Abstract][Full Text] [Related]
20. Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts in HIV-infected Mexican mestizos. Hernández-Ramírez D; Esparza-Pérez MA; Ramirez-Garcialuna JL; Arguello JR; Mandeville PB; Noyola DE; García-Sepúlveda CA Immunogenetics; 2015 Aug; 67(8):413-24. PubMed ID: 26033692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]